Minimally invasive treatment revolutionized cardiac medicine, replacing open-heart surgery for many patients CHICAGO, Aug. 26, 2020 /PRNewswire/ — Northwestern Medicine Bluhm Cardiovascular Institute physicians recently completed their 2000th transcatheter heart valve procedure, a milestone innovation that has shifted valve repair and replacement from operating room to catherization lab, dramatically reducing procedural time, recovery […]
Coronary/Structural Heart
New Amgen Data To Be Presented At ESC Congress 2020 Highlighting Repatha® (evolocumab) Efficacy In High-Risk Patient Populations
Repatha (Evolocumab) Late-Breaking Data Showcase First Phase 3 Study of a PCSK9 Inhibitor in Pediatric Heterozygous Familial Hypercholesterolemia New Data Highlight Gaps in Treating High LDL-C to Clinical Treatment Guidelines in a Large Cohort of European, High-Risk CVD Patients THOUSAND OAKS, Calif., Aug. 25, 2020 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced the […]
Medtronic Evolut TAVR System Receives Updated U.S. Labeling Revising Precaution for Treatment of Low-Risk Patients with Bicuspid Aortic Stenosis
Revised Commercial Labeling Broadens Patient Population Who May be Candidates for Transcatheter Aortic Valve Replacement (TAVR) DUBLIN, Aug. 21, 2020 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the U.S. Food and Drug Administration (FDA) has approved revised commercial labeling for the Evolut™ TAVR platform […]
Medicure Announces AGGRASTAT® Shows Promise in Treating Thrombotic Complications Due to COVID-19 in Early Clinical Reports
WINNIPEG, MB, Aug. 24, 2020 /PRNewswire/ – Medicure Inc. (“Medicure” or the “Company“) (TSXV:MPH, OTC:MCUJF), a pharmaceutical company, is reporting that early investigator sponsored clinical reports evaluating the efficacy of AGGRASTAT® (tirofiban hydrochloride) show promise for preventing and treating thrombotic complications due to COVID-19. AGGRASTAT® is not currently indicated for use in patients with COVID-19. […]
Jasper Capital Announces First Successful Implant of Guardian® Heart Attack Alarm System in Patients
First and Only Technology Providing Continuous Real-Time Alerting of Heart Attacks SINGAPORE–(BUSINESS WIRE)–Jasper Capital Ltd www.jasperCL.com (“Jasper”), a private equity fund with operations in Singapore and Silicon Valley, today announced the first successful implant of an implantable commercial heart attack alarm system, called the Guardian® system, developed by its portfolio company, Angel […]
Children’s Minnesota and Mayo Clinic announce pediatric cardiovascular collaboration
Now one of the largest and strongest pediatric cardiovascular programs in the country MINNEAPOLIS, Aug. 18, 2020 /PRNewswire/ — Children’s Minnesota and Mayo Clinic announced today that they have reached the next phase of an agreement to collaborate in the care of children with congenital heart disease. This phase of the agreement adds pediatric […]
First AngelMed Guardian® Implants in Asia Pacific
EATONTOWN, N.J., Aug. 18, 2020 /PRNewswire/ — Key Highlights: First AngelMed Guardian® patient implants in Asia Pacific for Hydrix Medical, a subsidiary of Hydrix Limited (ASX: HYD) Four implants were carried out under the guidance of leading Cardiologist Dr. Leslie Lam This significant milestone provides a foundation for future implants under early access schemes in Singapore and Australia Angel […]
Virginia Cardiovascular Specialists Deploys PatientKeeper to Enable Providers to Access Patient Records and Capture Charges on Mobile Devices
EHR optimization software streamlines workflow for physicians practicing at Richmond-area HCA Virginia and Bon Secours hospitals WALTHAM, Mass., and RICHMOND, Va., Aug. 18, 2020 /PRNewswire/ — Virginia Cardiovascular Specialists (VCS), a leading cardiology practice in Richmond, VA, has deployed PatientKeeper® to enable its providers to have immediate access to patient records and to enter professional charges, anytime, […]
Akcea and Ionis to Present Phase 2 Results of AKCEA-APOCIII-L(Rx) in Late-Breaking Presentation at ESC Congress 2020
Data presentation will highlight efficacy, safety and tolerability of investigational medicine in patients with hypertriglyceridemia and cardiovascular disease BOSTON and CARLSBAD, Calif., Aug. 18, 2020 /PRNewswire/ — Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), today announced that data from the Phase 2 study of AKCEA-APOCIII-LRx will be […]
Cytokinetics Announces Partnership to Improve Prediction of Risk and Outcomes in Hypertrophic Cardiomyopathy
Company Makes Long-term Commitment to Outcomes Research in HCM SOUTH SAN FRANCISCO, Calif., Aug. 18, 2020 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq:CYTK) today announced a $1 million grant and four-year partnership with the HCM Registry (HCMR), a global registry of patients with hypertrophic cardiomyopathy (HCM) focused on improving predictive measures […]



